Australia's most trusted
source of pharma news
Posted 11 June 2024 PM
ASX-listed Paragon Care has successfully completed its merger with CH2 Holdings in what's been described as a 'transformative transaction' expected to create a new leading wholesaler, distributor and manufacturing operation servicing healthcare markets across the Asia Pacific region.
The merger enables Paragon Care to facilitate expansion into both existing companies' healthcare wholesaling and distribution networks across Australia, New Zealand and Asia. The merger is a strategic move to strengthen the companies' combined operational capabilities in rapidly growing markets, with direct operations in eight countries.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.